Brief: Biostage Director Thomas Robinson reports open market purchase
May 20 (Reuters) - Biostage Inc BSTG.O :
* Director Thomas Robinson reports open market purchase of
18,000 shares of co's common stock on May 19 at average price of
$1.35 each - sec filing
Source text - (http://1.usa.gov/1NBLhHT)
Further company coverage: BSTG.O
((Bengaluru Newsroom: +1-646-223-8780;))
Recent news on Harvard Apparatus Regenerative Technology
See all newsBrief: Harvard Apparatus Regenerative Technology Announces Strategic Collaboration With Children’S Hospital Capital Institute Of Pediatrics In Beijing, China To Advance Treatment For Esophageal Atresia
Brief: Biostage Activated Mayo Clinic As The First Site For Clinical Trial In Severe Esophageal Disease
Brief: Biostage Amends CEO Employment Agreement
Brief: Biostage Inc Files For Firm Commitment Public Offering Of 1.03 Million Units - SEC Filing
Brief: Biostage Announces Appointment Of New Chief Financial Officer